Clinical Trial Detail

NCT ID NCT02126553
Title Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Lenalidomide

Age Groups: adult senior

Additional content available in CKB BOOST